Chimerix, Inc.
Pyrrolopyrimidine nucleosides and analogs thereof

Last updated:

Abstract:

The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein R.sub.c and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

18 May 2017

Issue date:

10 Sep 2019